INIS
viruses
100%
humans
52%
hepatitis
47%
liver
41%
transplants
29%
diseases
23%
mortality
23%
hemophilia
23%
hazards
17%
data
11%
patients
11%
universities
5%
therapy
5%
risks
5%
organs
5%
multivariate analysis
5%
males
5%
Medicine and Dentistry
Human Immunodeficiency Virus
47%
Hepatitis C Virus
41%
Transplantation
29%
Hepatitis Virus
23%
Haemophilia
23%
Mortality
23%
Patient
23%
Hazard Ratio
17%
Disease Exacerbation
11%
Liver Disease
11%
Liver Transplantation
11%
Male
11%
Univariate Analysis
5%
Mixed Infection
5%
Multivariate Analysis
5%
Antiretroviral Therapy
5%
Human Immunodeficiency Virus Infection
5%
Predictor
5%
Liver Graft
5%
Hepatitis C
5%
Age
5%
Model for End-Stage Liver Disease
5%
Survival
5%
Organ
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
47%
Hepatitis C Virus
41%
Observational Study
35%
Hemophilia
23%
Virus Hepatitis
23%
Mortality
23%
Disease Exacerbation
11%
Liver Disease
11%
Human Immunodeficiency Virus Infection
5%
Hepatitis C
5%
Mixed Infection
5%
Survival
5%
Immunology and Microbiology
Human Immunodeficiency Virus
47%
Hepatitis C Virus
47%
Transplantation
35%
Liver
29%
Mortality
23%
Liver Transplantation
11%
CD4
5%
Coinfection
5%
Platelet Count
5%
Age
5%
Organ
5%
Survival
5%
Human Immunodeficiency Virus Infection
5%
Viral Disease
5%
Nursing and Health Professions
Transplantation
29%
Hemophilia
23%
Virus Hepatitis
23%
Mortality
23%
Disease Exacerbation
11%
Liver Disease
11%
Liver Transplantation
11%
Univariate Analysis
5%
Antiretroviral Therapy
5%
Multivariate Analysis
5%
Human Immunodeficiency Virus Infection
5%
Platelet Count
5%
Liver Graft
5%
Hepatitis C
5%
Mixed Infection
5%
Survival
5%